Novotek AB (NTEK-B) Fair Value & Analysis
Technology · SE · Market cap 562M SEK
Fair value as of: Jul 16, 2026
From 24 valuation models · updated 6 days ago
Share price +13.1% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 50.50 – kr 114.66 · fair‑value band kr 62.96 – kr 107.42 · the kr 57.70 price screens below the kr 85.93 fair value. As of Jul 16, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Novotek AB (NTEK-B) currently trades at kr 57.70, while our model-based Fair Value estimate is kr 85.93, implying the stock looks roughly 48.9% undervalued today. We read business quality at 46/100 (below-average quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Novotek AB generated revenue of 505M SEK at a net margin of 6.9%. Revenue grew 1.4% year over year. It earns a return on equity of 15.4%. The balance sheet holds a net cash position of 116M SEK. Fundamentals as of Jul 16, 2026
Our scenario range runs from kr 62.96 (bear case) to kr 107.42 (bull case); at kr 57.70, the current price sits below that range. The share trades about 50% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -15% fair-value upside, at 49%, NTEK-B screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.
About the company
Novotek AB delivers solutions in the industrial IT and automation areas. The company designs, implements, evolves, and maintains its customers' systems for production management and control. It serves the energy, food, pharmaceuticals, iron, steel, chemistry, petrochemicals, paper, pulp, manufacturing, and water and wastewater industries. The company is located in Sweden, Norway, Denmark, Finland, Benelux, the United Kingdom, Ireland, Switzerland, Austria, Germany, and France. Novotek AB was incorporated in 1955 and is headquartered in Malmö, Sweden.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Novotek AB reported revenue of kr 503M in FY2025 versus kr 391M in FY2021, a compound +6.5%/yr. Reported net income was kr 39.1M in FY2025, compounding −0.4%/yr from FY2021.
Is NTEK-B fairly valued? → Check now
Similar stocks
10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| International Business Machines Corporation IBM | C$38.97 | C$24.52 | -37% |
| Accenture plc ACNN | 2,981 MXN | 250.14 MXN | -92% |
| Tata Consultancy Services Limited TCS | ₹2,199 | ₹1,863 | -15% |
| Infosys Limited I1FO34 | R$31.71 | R$32.08 | +1% |
| HCL Technologies Limited HCLTECH | ₹1,131 | ₹2,568 | +127% |
| Fiserv, Inc F1IS34 | R$138.03 | R$210.65 | +53% |
| Cognizant Technology Solutions Corporation CTSH | 961.80 MXN | 94.31 MXN | -90% |
| Wipro Limited WIPRO | ₹198.37 | ₹205.08 | +3% |
| CDW Corporation C1DW34 | R$33.03 | R$6.15 | -81% |
| Tech Mahindra Limited TECHM | ₹1,484 | ₹987.96 | -33% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Novotek AB (NTEK-B) undervalued?
What is the fair value of NTEK-B?
What is the quality score of NTEK-B?
What is the revenue of Novotek AB (NTEK-B)?
What is the net profit margin of NTEK-B?
Does Novotek AB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Novotek AB analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.